PURPLE BIOTECH LTD

Insiders Purple Biotech Ltd Nasdaq

Equities

PPBT

US74638P1093

Market Closed - Nasdaq Other stock markets 02:00:00 06/07/2024 am IST			5-day change	1st Jan Change
0.34 ^USD	-6.23%		-16.46%	-56.41%

27/06	Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise	MT
27/06	Purple Biotech Ltd. Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Purple Biotech Ltd. Announces Executive Changes	20/12	CI
Kitov Pharmaceuticals Holdings Ltd. Announces Appointment of Gill Ben-Menachem as Director	07/17/07	CI
Kitov Pharmaceuticals Holdings Announces Board Changes	03/17/03	CI
Kitov Pharmaceuticals Holdings Ltd. Announces Resignation of Ms. Leah Bruck as Independent Director	26/17/26	CI
Kitov Pharmaceuticals Holdings Ltd Appoints Ido Agmon as an Independent Director and to its Audit Committee	27/16/27	CI
Kitov Pharmaceuticals Holdings Ltd. Announces Board Changes	27/16/27	CI
Kitov Pharmaceuticals Holdings Ltd. Announces Resignation of Moran Sherf Blau from the Board of Directors and all Board Committees	27/16/27	CI
Kitov Pharmaceuticals Holdings Ltd Appoints Mr. Steven Steinberg to Serve as Director	13/16/13	CI
Kitov Pharmaceuticals Holdings Ltd. Appoints Ido Agmon as Director	27/16/27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer